128 related articles for article (PubMed ID: 20332144)
1. Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding.
Hamaoka M; Chinen I; Murata T; Takashima S; Iwamoto R; Mekada E
J Biochem; 2010 Jul; 148(1):55-69. PubMed ID: 20332144
[TBL] [Abstract][Full Text] [Related]
2. Ectodomain shedding of HB-EGF: a potential target for cancer therapy.
Miyazono K
J Biochem; 2012 Jan; 151(1):1-3. PubMed ID: 21976708
[TBL] [Abstract][Full Text] [Related]
3. Hamster diphtheria toxin receptor: a naturally occurring chimera of monkey and mouse HB-EGF precursors.
Cha JH; Brooke JS; Eidels L
Biochem Biophys Res Commun; 1999 Jan; 254(2):325-9. PubMed ID: 9918837
[TBL] [Abstract][Full Text] [Related]
4. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
Toki F; Nanba D; Matsuura N; Higashiyama S
J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
[TBL] [Abstract][Full Text] [Related]
5. A novel anti-human HB-EGF monoclonal antibody with multiple antitumor mechanisms against ovarian cancer cells.
Miyamoto S; Iwamoto R; Furuya A; Takahashi K; Sasaki Y; Ando H; Yotsumoto F; Yoneda T; Hamaoka M; Yagi H; Murakami T; Hori S; Shitara K; Mekada E
Clin Cancer Res; 2011 Nov; 17(21):6733-41. PubMed ID: 21918176
[TBL] [Abstract][Full Text] [Related]
6. Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells.
Singh AB; Tsukada T; Zent R; Harris RC
J Cell Sci; 2004 Mar; 117(Pt 8):1365-79. PubMed ID: 14996914
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal visualization of proHB-EGF ectodomain shedding in living cells.
Inoue H; Sakaue T; Ozawa T; Higashiyama S
J Biochem; 2013 Jul; 154(1):67-76. PubMed ID: 23598347
[TBL] [Abstract][Full Text] [Related]
8. Roles of charged amino acid residues in the cytoplasmic domain of proHB-EGF.
Nanba D; Toki F; Higashiyama S
Biochem Biophys Res Commun; 2004 Jul; 320(2):376-82. PubMed ID: 15219838
[TBL] [Abstract][Full Text] [Related]
9. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity.
Mitamura T; Higashiyama S; Taniguchi N; Klagsbrun M; Mekada E
J Biol Chem; 1995 Jan; 270(3):1015-9. PubMed ID: 7836353
[TBL] [Abstract][Full Text] [Related]
10. GPI-anchored diphtheria toxin receptor allows membrane translocation of the toxin without detectable ion channel activity.
Lanzrein M; Sand O; Olsnes S
EMBO J; 1996 Feb; 15(4):725-34. PubMed ID: 8631294
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a Novel Anti-Human HB-EGF Monoclonal Antibody Applicable for Paraffin-Embedded Tissues and Diagnosis of HB-EGF-Related Cancers.
Iwamoto R; Takagi M; Akatsuka J; Ono K; Kishi Y; Mekada E
Monoclon Antib Immunodiagn Immunother; 2016 Apr; 35(2):73-82. PubMed ID: 26974561
[TBL] [Abstract][Full Text] [Related]
12. Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth.
Inui S; Higashiyama S; Hashimoto K; Higashiyama M; Yoshikawa K; Taniguchi N
J Cell Physiol; 1997 Jun; 171(3):291-8. PubMed ID: 9180898
[TBL] [Abstract][Full Text] [Related]
13. Diphtheria toxin:receptor interaction: association, dissociation, and effect of pH.
Brooke JS; Cha JH; Eidels L
Biochem Biophys Res Commun; 1998 Jul; 248(2):297-302. PubMed ID: 9675130
[TBL] [Abstract][Full Text] [Related]
14. Structure-function analysis of the diphtheria toxin receptor toxin binding site by site-directed mutagenesis.
Mitamura T; Umata T; Nakano F; Shishido Y; Toyoda T; Itai A; Kimura H; Mekada E
J Biol Chem; 1997 Oct; 272(43):27084-90. PubMed ID: 9341148
[TBL] [Abstract][Full Text] [Related]
15. Immunoneutralization of growth differentiation factor 9 reveals it partially accounts for mouse oocyte mitogenic activity.
Gilchrist RB; Ritter LJ; Cranfield M; Jeffery LA; Amato F; Scott SJ; Myllymaa S; Kaivo-Oja N; Lankinen H; Mottershead DG; Groome NP; Ritvos O
Biol Reprod; 2004 Sep; 71(3):732-9. PubMed ID: 15128595
[TBL] [Abstract][Full Text] [Related]
16. Carboxyl-terminal truncation of leucine76 converts heparin-binding EGF-like growth factor from a heparin-enhancible to a heparin-suppressible growth factor.
Cook PW; Damm D; Garrick BL; Wood KM; Karkaria CE; Higashiyama S; Klagsbrun M; Abraham JA
J Cell Physiol; 1995 May; 163(2):407-17. PubMed ID: 7706382
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to the EGF receptor act as betacellulin antagonists.
Modjtahedi H; Dean C
Biochem Biophys Res Commun; 1996 Apr; 221(3):625-30. PubMed ID: 8630011
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction.
Borer JG; Park JM; Atala A; Nguyen HT; Adam RM; Retik AB; Freeman MR
Lab Invest; 1999 Nov; 79(11):1335-45. PubMed ID: 10576204
[TBL] [Abstract][Full Text] [Related]
19. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
20. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor.
Shishido Y; Sharma KD; Higashiyama S; Klagsbrun M; Mekada E
J Biol Chem; 1995 Dec; 270(49):29578-85. PubMed ID: 7494001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
